Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pilomatrical carcinosarcoma in the very elderly: A case report.

Molecular and clinical oncology·2021

Same author

A case of high-grade mucinous tubular and spindle cell carcinoma.

Journal of surgical case reports·2020

Same author

An Autopsy Case of Rupture of Infectious Thoracic Aortitis Induced by Methicillin-Resistant Staphylococcus Aureus.

The American journal of case reports·2019

Same author

Malignant rhabdoid tumour in an adult kidney: A case report.

Molecular and clinical oncology·2019

Same author

Extra-gastrointestinal stromal tumor with a large cyst.

Journal of surgical case reports·2019

Same author

Large-cell neuroendocrine carcinoma arising in the endometrium: A case report.

Molecular and clinical oncology·2018

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

A new bone marrow transplantation method for stem cell disorders.

Susumu Ikehara¹

¹First Department of Pathology, Transplantation Center, Kansai Medical University, Moriguchi City, Japan. ikehara@takii.kmu.ac.jp

Annals of the New York Academy of Sciences

|September 18, 2009

Summary

A novel perfusion method (PM) plus intrabone marrow (IBM)-bone marrow transplantation (BMT) treats autoimmune diseases by minimizing T cell contamination. This method also identifies age-associated diseases as mesenchymal stem cell (MSC) disorders.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Jun 20, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Area of Science:

Regenerative Medicine
Stem Cell Biology
Transplantation Immunology

Background:

Autoimmune diseases are linked to hematopoietic stem cell (HSC) disorders.
Previous studies demonstrated allogeneic bone marrow transplantation (BMT) efficacy in treating autoimmune diseases in animal models.
A need exists for improved BMT methods to enhance engraftment and prevent complications like graft-versus-host disease.

Purpose of the Study:

To introduce a new BMT method combining a perfusion method (PM) with intrabone marrow (IBM)-BMT.
To investigate the role of mesenchymal stem cells (MSCs) in age-associated diseases.
To propose a unified concept of stem cell disorders encompassing both HSC and MSC disorders.

Main Methods:

Developed a novel perfusion method (PM) to collect bone marrow cells (BMCs), minimizing peripheral blood T cell contamination.
Administered BMCs, containing both HSCs and MSCs, via intrabone marrow (IBM)-BMT.
Utilized animal models to assess the efficacy of the new BMT method and evaluate age-associated diseases.

Main Results:

The PM-IBM-BMT method successfully prevented graft-versus-host disease.
Bone marrow cells collected by PM contained both HSCs and MSCs, facilitating donor cell engraftment.
Evidence suggests that age-associated diseases like osteoporosis and emphysema are MSC disorders.

Conclusions:

The PM-IBM-BMT method represents a significant advancement in transplantation, reducing complications and improving engraftment.
Age-associated diseases may stem from MSC dysfunction, expanding the understanding of stem cell disorders.
This research proposes a paradigm shift in transplantation and regenerative medicine by recognizing both HSC and MSC disorders.